ArticleNature machine intelligence2026
Empowering biomedical evidence exploration and synthesis with deep knowledge graph research.
Article in Nature machine intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An agentic AI framework connecting language models to electronic health records and a biomedical knowledge graph for real-world evidence.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Compared with generic artificial intelligence agents, deep research agents perform longer-horizon reasoning and deeper literature exploration to investigate complex questions. Here we present DeepEvidence, a deep research agent for evidence exploration and synthesis across heterogeneous biomedical knowledge sources. DeepEvidence advances deep research through coordinated multi-agent collaboration combining breadth-first and depth-first research strategies to search, explore and aggregate evidence from multiple biomedical knowledge bases and literature. It also incrementally constructs an evidence graph of key entities and observations to support transparent tracking, attribution and validation of the research process. DeepEvidence substantially outperforms generic artificial intelligence agents across four open benchmarks. We further establish seven benchmark tasks spanning major stages of biomedical discovery, including drug discovery, preclinical experimentation, clinical trial development and evidence-based medicine. DeepEvidence demonstrates substantial improvements in systematic evidence exploration and synthesis. These results highlight the potential of deep research agents to accelerate biomedical discovery and translational research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.